Company Overview of Syndax Pharmaceuticals, Inc.
Key Executives for Syndax Pharmaceuticals, Inc.
|Briggs W. Morrison M.D.||16 Relationships||Chief Executive Officer and Director||56|
|Michael A. Metzger M.B.A.||8 Relationships||President and Chief Operating Officer||45|
|Michael Downes Ph.D.||No Relationships||Co-Founder||--|
|Ronald M. Evans Ph.D.||61 Relationships||Co-Founder, Advisor and Chair of Scientific Advisory Board||--|
|Richard A. Heyman Ph.D.||43 Relationships||Co-Founder||59|
|View More Key Executives|
Syndax Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Dennis G. Podlesak MBA||31 Relationships||Domain Associates, L.L.C.||58|
|Briggs W. Morrison M.D.||16 Relationships||Syndax Pharmaceuticals, Inc.||56|
|Ronald M. Evans Ph.D.||61 Relationships||Syndax Pharmaceuticals, Inc.||--|
|Luke B. Evnin Ph.D.||98 Relationships||Blade Therapeutics, Inc.||53|
|Pierre Legault CA, MBA, CPA||54 Relationships||Poxel SA||55|
Syndax Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee CA, MBA, CPA||Pierre Legault||54 Relationships||3 Executives|
|Compensation Committee Ph.D.||Luke B. Evnin||98 Relationships||3 Executives|
|Nominating Committee MBA||Dennis G. Podlesak||31 Relationships||3 Executives|
|Corporate Governance Committee MBA||Dennis G. Podlesak||31 Relationships||3 Executives|
|Advisory Board Ph.D.||Ronald M. Evans||61 Relationships||10 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$625.4K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.